Research Options:

Week of Expected Pricing 7/21/2022
Company Name VIRAX BIOLABS GROUP LTD
Proposed Ticker VRAX
CUSIP G9495L109
Business Description A global innovative biotechnology group that primarily engages in sales, distribution and marketing of diagnostics test kits and med-tech and Personal Protective Equipment (“PPE”) products for the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. Our mission is to minimize the risks of viruses throughout the world via our products offerings.
Lead Underwriter Boustead Securities, LLC, Valuable Capital Limited
Co-Managers N/A
Initial Shares 13,50,000
Revised Initial Shares N/A
Initial Price $5.00-$5.00
Revised Price N/A
Final Price $5.00
Final Ticker VRAX

 

 

   
  © 2024 ICE Data Services. All rights reserved.